Uncategorized

Gene-based factor VIIa prevents bleeding episodes in animals with hemophilia: Preclinical work offers first target levels for bypass agent prophylaxis in future human trials

Hematology researchers have further refined how a treatment currently used on an urgent basis to control bleeding in hemophilia patients

Read more